iShares Nasdaq Biotechnology ETF (IBB)

103.92
BATS BZX Real-Time Price
As of 2:51pm ET
 +0.28 / +0.27%
Today’s Change
100.22
Today|||52-Week Range
122.97
-2.67%
Year-to-Date

Investment Objective

The investment seeks to track the investment results of the NASDAQ Biotechnology Index- which contains securities of companies listed on NASDAQ that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq- Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures- options and swap contracts- cash and cash equivalents. It is non-diversified.

Eye Drug Continues to Drive Regeneron's Growth
Dec 04 / GuruFocus News - Paid Partner Content
 

Performance

1 month-6.86% 3 years-1.24%
3 months-12.08% 5 years+7.11%
1 year-0.28% Since inception+6.72%
Data through 12/08/2018

Quote Details

Previous close$103.64
Open day’s range101.27 – 104.26
Net asset value (NAV)103.50 (12/07/2018)
Daily volume128,222
Average volume (3 months)1,968,388
Data as of 2:51pm ET, 12/10/2018

Peer Comparisonvs. Health ETFs

 IBBCategory
Performance 5-yr return+7.11%+14.62%
Expense Gross exp ratio0.47%1.28%
Risk 5 year sharpe ratio0.430.76
Net assets$8.4B$3.4B
Average market cap$17.0B$27.2B
Average P/E30.227.5
Dividend / Share--0.28%

Competitors

IHI iShares U.S. Medical Devices ETF
FHLC Fidelity® MSCI Health Care Index ETF
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Invesco S&P 500® Equal Weight Health Ca...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 99.91%
Business service 0.09%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
AMGN Amgen9.30%
GILD Gilead Sciences8.48%
BIIB Biogen8.42%
CELG Celgene6.54%
ILMN Illumina Inc6.38%
VRTX Vertex Pharmaceuticals Inc4.37%
REGN Regeneron Pharmaceuticals4.01%
ALXN Alexion Pharmaceuticals Inc3.70%
MYL Mylan NV2.35%
BMRN Biomarin Pharmaceutical Inc2.30%